Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2015-08-01 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BEGLES (33130), Gironde
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BARRIERE DE BEGLES : revenue, balance sheet and financial ratios
PHARMACIE BARRIERE DE BEGLES is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BEGLES (33130),
this company of category PME
shows in 2025 a net income positive of 91 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BARRIERE DE BEGLES (SIREN 812938603)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
91 459 €
90 315 €
90 983 €
103 056 €
103 216 €
90 231 €
96 165 €
64 102 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE BARRIERE DE BEGLES generates positive net income of 91 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 64 k€ -> 91 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
91 459 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 80%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
80.142%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
50.057%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE BARRIERE DE BEGLES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
678.133
417.085
312.36
224.932
168.723
130.508
102.674
80.142
Financial autonomy
11.435
17.095
21.979
27.767
33.19
38.459
44.168
50.057
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
80.142025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average-6 pts over 3 years
In 2025, the debt ratio of PHARMACIE BARRIERE DE BEGLES (80.14) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
50.06%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average+8 pts over 3 years
In 2025, the financial autonomy of PHARMACIE BARRIERE DE BEGLES (50.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 157.56. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
157.565
Liquidity indicators evolution PHARMACIE BARRIERE DE BEGLES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
104.055
104.692
152.361
156.402
157.464
152.237
159.519
157.565
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
157.562025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average+5 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE BARRIERE DE BEGLES (157.56) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE BARRIERE DE BEGLES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE BARRIERE DE BEGLES is estimated at
1 452 837 €
(range 985 902€ - 2 279 701€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
985k€1452k€2279k€
1 452 837 €Range: 985 902€ - 2 279 701€
NAF 5 année 2025
Valuation method used
Net Income Multiple
91 459 €
×
15.9x
=1 452 837 €
Range: 985 902€ - 2 279 701€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BARRIERE DE BEGLES with other companies in the same sector:
Frequently asked questions about PHARMACIE BARRIERE DE BEGLES
What is the revenue of PHARMACIE BARRIERE DE BEGLES ?
The revenue of PHARMACIE BARRIERE DE BEGLES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE BARRIERE DE BEGLES profitable?
Yes, PHARMACIE BARRIERE DE BEGLES generated a net profit of 91 k€ in 2025.
Where is the headquarters of PHARMACIE BARRIERE DE BEGLES ?
The headquarters of PHARMACIE BARRIERE DE BEGLES is located in BEGLES (33130), in the department Gironde.
Where to find the tax return of PHARMACIE BARRIERE DE BEGLES ?
The tax return of PHARMACIE BARRIERE DE BEGLES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BARRIERE DE BEGLES operate?
PHARMACIE BARRIERE DE BEGLES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart